(MENAFN) On Sunday, October Pharma's ordinary general meeting (OGM) will convene to discuss the company's dividend distributions among other items.
October Pharma's board had recommended a cash dividend amounted at EGP 24 million, representing 40% of capital, for 2017.
The OGM will also explore the prospects of opening a legal unit, subsidiary, or entity in the UAE.
October Pharma last reported a 60% surge in profits to EGP 56 million in 2017 from EGP 35 million in 2016; the rise came on the back of higher revenues, which grew to EGP 350 million last year from EGP 288 million the previous year.
MENAFN1803201800450000ID1096611686
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.